Influenza: Biology, infection, and control

Emerging Infections in Asia

Volumn , Issue , 2008, Pages 3-30

  Roberts, Bryan ^a  

^a Apex Consulting Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951789305     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-75722-3_1     Document Type: Chapter

References (103)

1. Almond, J. W. (1977). A single gene determines the host range of influenza. Nature, 270, 617-618.
2. Alexander, D. J. (2000). A Review of avian influenza in different bird species. Veterinary Microbiology 74, 3-13.
3. Baigent, S. J., & McCauley, J. W. (2003). Influenza type A in humans, mammals and birds: Determinants of virus host-range and interspecies transmission. BioEssays, 25, 657-671.
4. Banks, J., Speidel, E. C., McCauley, J. W., & Alexander, D. J. (2000). Phylogenetic analysis of H7 hemagglutinin subtype influenza A viruses. Archives of Virology, 145, 1047-1058.
5. Banks, J., Speidel, E. C., Moore, E., Plowright, L., Piccirillo, A., Capua, I., Cordioli, P., Fioretti, A., & Alexander, D. J. (2001). Changes in the hemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Archives of Virology, 146, 963-973.
6. Barry, J. M. (2004). The Great Influenza. Penguin, Harmondsworth.
7. Barry, D. W., Mayner, R. E., Meisler, J. M., & Seligmann Jr., E. B. (1977). Evaluation and control of vaccines for the National Influenza Immunization Program. Journal of Infectious Diseases, 136, S407-S414.
8. Bean, W. J., & Webster, R. G. (1978). Phenotypic properties associated with influenza genome segments. In Negative Strand Viruses and the Host Cell (Mahy, B. W. J., & Barry, R. D., Eds), pp. 685-692. Academic, London.
9. Black, R. A., Rota, P. A., Gorodkova, N., Klenk, H. D., & Kendal, A. P. (1993). Antibody response of the M2 protein of influenza A virus expressed in insect cells. Journal of General Virology, 74, 143-146.
10. Bright, R. A., Shay, D. K., Shu, B., Cox, N. J., & Klimov, A. I. (2006). Adamatane resistance among Influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA, 295(8), 891-894.
11. Brown, F., Robertson, J. S., Schild, G. C., & Wood, J. M. (1999). Inactivated influenza vaccines prepared in cell culture. Developments in Biological Standardization, 98.
12. Brugha, R., Sterling, M., & Walt, G. (2002). GAVI, the first steps: Lessons for the Global Fund. Lancet, 359, 435-438.
13. Capua, I., & Alexander, D. J. (2004). Avian influenza: Recent developments. Avian Pathology, 33, 393-404.
14. Capua, I., & Marangon, S. (2000). The avian influenza epidemic in Italy, 1999-2000: a review. Avian Pathology, 29, 289-294.
15. Chen, H., Smith, G. J. D., Zhang, S. Y., Qin, K., Wang, J., Li, K. S., Webster, R. G., Peiris, J. S. M., & Guan, Y. (2005). H5N1 virus outbreak in migratory waterfowl. Nature, 436, 191-192.
16. Cleaveland, S., Laurenson, M. K., & Taylor, L. H. (2001). Diseases of humans and their domestic mammals: Pathogen characteristics, host range and the risk of emergence. Philosophical Transactions of the Royal Society of London. Series B, 356, 991-999.
17. Connor, R. J., Kawaoka, Y., Webster, R. G., & Paulson, J. C. (1994). Receptor specificity in human, avian and equine H2 and H3 influenza isolates. Virology, 205, 17-23.
18. Cox, N. J., & Subbarao, K. (2000). Global epidemiology of influenza: Past and present. Annual Reviews of Medicine, 51, 407-421.
19. Daly, J. M., Newton, J. R., & Mumford, J. A. (2004). Current perspectives on control of equine influenza. Veterinary Research, 35, 411-423.
20. Epstein, S. L., Tumpey, T. M., Misplon, J. A., Lo, C-Y., Cooper, L. A., Subbarao, K., Renshaw, M., Sambhara, S., & Katz, J. M. (2002). DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerging Infectious Diseases, 8, 796-801.
21. Fan, J., Liang, X., Horton, M. S., Perry, H. C., Citron, M. P., Heidecker, G. J., Fu, T-M., Joyce, J., Przysiecki, C. T., Keller, P. M., Garsky, V. M., Ionescu, R., Rippeon, Y., Shi, L., Chastain, M. A., Condra, J. H., Davies, M-E., Liao, J., Emini, E. A., & Shiver, J. W. (2004). Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets and rhesus monkeys. Vaccine, 22, 2993-3003.
22. Ferguson, N. M., Cummings, D. A. T., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S., & Burke, D. S. (2005). Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature, 437, 209-214.
23. Fiers, W., De Filette, M., Birkett, A., Nierynck, S., & Min Jou, W. (2004). A universal influenza A vaccine. Virus Research, 103, 173-176.
24. Fouchier, R. A. M., Osterhaus, A. D. M. E., & Brown, I. H. (2003). Animal influenza virus surveillance. Vaccine, 21, 1754-1757.
25. Francis Jr., T., Salk, J. E., & Quilligan, J. J. J. (1947). Experience with vaccination against influenza in the spring of 1947. American Journal of Public Health, 37, 1013-1016.
26. Gambaryan, A. S., Piskarev, V. E., Yamskov, I. A., Sakharov, A. M., Tuzikov, A. B., Bovin, N. V., Nifant'ev, N. E., & Matrosovich, M. N. (1995). Human influenza virus recognition of oligosaccharides. FEBS Letters, 366, 57-60.
27. Garcia, M., Crawford, J. M., Latimer, J. W., Rivera Cruz, E., & Perdue, M. L. (1996). Heterogeneity in the hemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza strains in Mexico. Journal of General Virology, 77, 1493-1504.
28. Garrett, L. (1994). The Coming Plague: Newly Emerging Diseases in a World Out of Balance. Farrar, Strauss and Giroux, New York.
29. Ghedin, E., Sengamalay, N. A., Shumway, M., Zaborsky, J., Feldblyum, T., Subbu, V., Spiro, D. J., Sitz, J., Koo, H., Bolotov, P., Dernovoy, D., Tatusova, T., Bao, Y., St George, K., Taylor, J. U., Lipman, D. J., Fraser, C. M., Taubenberger, J. K., & Salzberg, S. L. (2005). Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature, 437, 1162-1166.
30. Glezen, W. P. (1996) Emerging Infections: Pandemic Influenza. Epidemiologic Reviews 18(1), 64-76.
31. Harvey, R., Martin, A. C. R., Zambon, M., & Barclay, W. S. (2004). Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human host. Journal of Virology, 78, 502-507.
32. Hayden, F., & Croisier, A. (2005). Transmission of avian influenza viruses to and between humans. Journal of Infectious Diseases, 192, 1311-1314.
33. Helenius, A. (1992). Unpacking the incoming influenza virus. Cell, 69, 577-578.
34. Hilleman, M. R. (1999). Personal historical chronicle of six decades of basic and applied research in virology, immunology and vaccinology. Immunological Reviews, 170, 7-27.
35. Hinshaw, V. S., Webster, R. G., & Turner, B. (1980). The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl, Journal of Microbiology, 26, 622-629.
36. Horimoto, T., & Kawaoka, Y. (2001). Pandemic threat posed by avian influenza A viruses. Clinical Microbiology Reviews, 14, 129-149.
37. Ionescu, R. M., Przysiecki, C. T., Liang, X., Garsky, V. M., Fan, J., Wang, B., Troutman, R., Pippeon, Y, Flanagan, E., Shiver, J., & Shi, L. (2006). Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. Journal of Pharmaceutical Science, 95, 70-79.
38. Ito, T., Gorman, O. T., Kawaoka, Y., Bean, W. J., & Webster, R. G. (1991). Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. Journal of Virology, 65, 5491-5498.
39. Karasin, A. I., Olsen, C. W., & Anderson, G. A. (2000). Genetic characterization of an H1N2 influenza isolated from a pig in Indiana. Journal of Clinical Microbiology, 38, 2453-2456.
40. Kawaoka, Y., Krauss, S., & Webster, R. G. (1989). Avian to human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. Journal of Virology, 63, 4603-4608.
41. Koen, J. S. (1919). A practical method for field diagnosis of swine diseases. American Journal of Veterinary Medicine, 14, 468-470.
42. Lamb, R. A., Zebedee, S. L., & Richardson, C. D. (1985). Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell, 40, 627-633.
43. Le, Q. M., Kiso, M., Someya, K., Sakai, Y., Nguyen, T, H., Nguyen, K. H. L., Dinh Pham, N., Nguyen, H. N., Yamada, S., Muramoto, Y. Horimoto, T., Takada, A., Goto, H. Suzuki, T., Suzuki, Y., & Kawaoka, Y. (2005). Isolation of drug resistant H5N1 virus. Nature, 437, 1108.
44. Levi, R., & Arnon, R. (1996). Synthetic recombinant influenza vaccine induces efficient longterm immunity and cross strain protection. Vaccine, 14, 85-92.
45. Liu, W., Peng, Z., Liu, Z., Lu, Y., Ding, J., & Chen, Y-H. (2004). High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine, 23, 366-371.
46. Longini, I. M., Nizam, A., Xu, S., Ungchusak, K., Hanshaoworakul, W., Cummings, D. A. T., & Halloran, M. E. (2005). Containing pandemic influenza at the source. Science, 309, 1083-1087.
47. Luk, J., Gross, P., & Thompson, W. W. (2001). Observations on mortality during the 1918 influenza pandemic. Clinical Infectious Diseases, 33, 1375-1378.
48. Maassab, H. F., & Bryant, M. L. (1999). The development of live attenuated cold adapted influenza virus vaccine for humans. Reviews in Medical Virology, 9, 237-244.
49. Matrosovitch, M., Tuzikov, A., Bovin, N., Gambaryan, A., Klimov, A., Castrucci, M. R., Donatelli, I., & Kawaoka, Y. (2000). Early alterations of the receptor-binding properties of H1, H2 and H3 avian influenza virus hemagglutinins after their introduction into mammals. Journal of Virology, 74, 8502-8512.
50. McMichael, A. J. (2004). Environmental and social influences on emerging infectious diseases: Past, present and future. Philosophical Transactions of the Royal Society of London. Series B, 359, 1049-1058.
51. Mozdzanowska, K., Feng, J. Q., Eid, M., Kragol, G., Cudic, M., Otvos, L., & Gerhard, W. (2003). Induction of Influenza type A virus specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine, 21, 2616-2626.
52. Murphy, F. A. (1996). Virus taxonomy. In Virology (Fields, B. N., Knipe, D. M. & Howley, P. M., Eds.), pp. 15-57, Lippincott-Raven, Philadelphia.
53. Murray, R. (1969). Production and testing in the USA of influenza virus vaccine made from the Hong Kong variant in 1868-69. Bulletin of the World Health Organization, 41, 495-496.
54. Naeem, K. (1998). The avian influenza outbreak in South Central Asia. In Proceedings of the International Symposium on Avian Influenza American Association of Avian Pathologists. Pennsylvania, Athens, Georgia, USA, pp. 31-35.
55. Nierynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Min Lou, W., & Fiers, W. (1999). A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nature Medicine, 5, 1157-1163.
56. Nobusawa, E., Ishihara, H., Morishita, T., Sato, K., & Nakajima, K. (2000). Change in receptorbinding specificity of recent human influenza A viruses (H3N2): A single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology, 278, 587-596.
57. Obenauer, J. C., Denson, J., Mehta, P. K., Su, X., Mukatira, S., Finkelstein, D. B., Xu, X., Wang, J., Ma, J., Fan, Y., Rakestraw, K. M., Webster, R. G., Hoffman, E., Krauss, S., Zheng, J., Zhang, Z., & Naeve, C. W. (2006). Large-scale sequence analysis of avian influenza isolates. Science, 311, 1576-1580.
58. Oxford, J. S., McGeoch, D. J., Schild, G. C., & Beare, A. S. (1978). Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature, 273, 778-779.
59. PAHO Meeting. (2005). Avian Influenza and Pandemic Preparedness: The Vaccine Industry Perspective. Washington, DC, 21 November 2005.
60. Palumbi, S. R. (2001). Humans as the world's greatest evolutionary force. Science. 293, 5536, 1786-1790.
61. Payne, A. M. (1953). The influenza programme of WHO. Bulletin of the World Health Organization, 8, 755-774.
62. Perdue, M., Crawford, J., Garcia, M., Latimer, J., & Swayne, D. (1998). Occurrence and possible mechanisms of cleavage site insertions in the avian influenza hemagglutinin gene. In Proceedings of the 4th International Symposium on Avian Influenza. Athens, Georgia, USA, pp. 182-193.
63. Perroncito, E. (1878). Epizoozia tifoide nei gallinacei. Annals of the Academy of Agriculture, 21, 87-93.
64. Petersen, L. R., & Roehrig, J. T. (2001). West Nile Virus: A reemerging global pathogen. Emerging Infectious Disease, 7(4), 611-614.
65. Potter, C. W. (2001). A history of influenza. Journal of Applied Microbiology, 91, 572-579.
66. Puzelli, S., Di Trani, L., Fabiani, C., Campitelli, L., De Marco, M. A., Capua, I, Aguilera, J. F., Zambom, M., & Donatelli, I. (2005). Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. Journal of Infectious Diseases, 192, 1318-1322.
67. Rappuoli, R., Miller, H. I., & Falkow, S. (2002). The intangible value of vaccines. Science, 297, 937-939.
68. Reid, A. H., Fanning, T. G., Janczewski, T. A., Lourens, R. M., & Tanbenberger, J. K. (2004). Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. Journal of Virology, 78, 12462-12470.
69. Roberts, B. E., & Lu, Y. (2004). Infectious Diseases in Asia: Implications for Global Health in Aids in Asia (Lu, Y. & Essex, M., Eds), Kluwer/Plenum, New York.
70. Rogers, G. N., Paulson, J. C., Daniels, R. S., Skehel, J. J., Wilson, I. A., & Wiley, D. C. (1983). Single amino acid substitutions in influenza haemagglutinin change receptor specificity. Nature, 304, 76-78.
71. Rohm, C., Horimoto, T., Kawaoka, Y., Suss, J., & Webster, R. G. (1995). Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology, 209, 664-670.
72. Rojas, H., Moreira, R., Avalos, P., & Marangon, S. (2002). Avian influenza in poultry in Chile. Veterinary Record, 151, 188.
73. Scholtissek, C., & Murphy, B. R. (1978). Host range mutants of an influenza A virus. Archives of Virology, 58, 323-333.
74. Shaw, M. W., Xu, X., Normand, S., Ueki, R. T., Kumimoto, G. Y., Hall, H, Kimov, A., Cox, N. J., & Subbarao, K. (2002). Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology, 303, 1-8.
75. Shinya, K., Ebinall, M., Shinya, Y., Ono, M., Kasai, N., & Kawaoka, Y. (2006). Influenza virus receptors in the human airway. Nature, 440, 435-436.
76. Shope, R. E. (1931). Swine influenza filtration experiments and etiology. Journal of Experimental Medicine, 54, 373-385.
77. Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H., & Schonberger, L. B. (1997). The impact of influenza epidemics on mortality: Introducing a severity index. American Journal of Public Health, 87, 1944-1950.
78. Simonsen, L., Clarke, M. J., Schonberger, L. B., et al. (1998). Pandemic versus epidemic influenza mortality: A pattern of changing age distribution. Journal of Infectious Diseases, 178, 53-60.
79. Slepushkin, V. A., Katz, J. M., Black R. A., Gamble, W. A., Rota, P. A., & Cox, N. J. (1995). Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13 (15) 1399-1402.
80. Smith, W., Andrews, C. H., & Laidlaw, P. P. (1933). A virus obtained from influenza patients. Lancet, 2, 66-68.
81. Steinhauer, D. A. (1999). Minireview role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology, 258, 1-20.
82. Stevens, J., Blixt, O, Tumpey, T. M., Taubenberger, J. K., Paulson, J. C., & Wilson, I. A. (2006). Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Sciencexpress Research article, http://www.sciencexpress.org, 20 March 2006.
83. Sturm-Ramirez, K. M., Hulse-Post, D. J., Govorkova, E. A., Humberd, J., Seiler, P., Puthavathana, P., Buranathai, C., Nguyen, T. D. Chaisingh, A., Long, H. T., Naipospos, T. S. P., Chen, H., Ellis, T. M., Guan, Y., Peiris, J. S. M., & Webster, R. G. (2005). Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? Journal of Virology, 79, 11269-11279.
84. Sugrue, R. J., & Hay, A. J. (1991). Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel. Virology, 180, 617-624.
85. Szucs, T. (1999). The socio-economic burden of influenza. The Journal of Antimicrobial Chemotherapy, 44, Topic B, 11-15.
86. Tilman, D. (1999). Global environmental impacts of agricultural expansion: The need for sustainable and efficient practices. Proceedings of the National Academy of Sciences of the United States of America, 96, 5995-6000.
87. Treanor, J. J., Snyder, M. H., London, W. T., & Murphy, B. R. (1989). The B allele of the NS gene of avian influenza viruses but not the A allele attenuates a human influenza A virus for squirrel monkeys. Virology, 171, 1-9.
88. Treanor, J. J., Tierney, E. L., Zebedee, S. L., Lamb, R. A., & Murphy, B. R. (1990). Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. Journal of Virology, 64, 1375-1377.
89. Uiprasertkul, M., Puthavathana, P., Sangsiriwut, K., Pooruk, P., Srisook, K., Peiris, M., Nicholls, J. M., Chokephaibulkit, K., Vanprapar, N., & Auewarakul, P. (2005). Influenza A H5N1 replication sites in humans. Emerging Infectious Diseases, 11, 1036-1041.
90. United Nations. (2004). World Population Prospects: The 2004 Revision. United Nations, New York.
91. Van Riel, D., Munster, V. J. De Wit, E. Rimmelzwaan, G. F., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Kuiken, T. (2006). H5N1 virus attachment to lower respiratory tract. Sciencexpress Brevia, http://www.sciencexpress.org, 23 March 2006.
92. Vijayanand, P., Wilkins, E., & Woodhead, M. (2004). Severe acute respiratory syndrome (SARS): A review. Clinical Medicine, 4, 152-160.
93. Villarreal, C. L., & Flores, A. O. (1997). The Mexican avian influenza H5N2 outbreak. In Proceedings of the International Symposium on Avian Influenza American Association of Avian Pathologists, Pennsylvania, Athens, Georgia, USA, pp. 18-22.
94. Webby, R. J., Swenson, S. L., Krauss, S. L., Gerrish, P. J., Goyal, S. M., & Webster, R. G. (2000). Evolution of swine H3N2 influenza viruses in the United States. Journal of Virology 74, 8243-8251.
95. Webster, R. G., & Kawaoka, Y. (1988). Avian influenza. Critical Reviews in Poultry Biology, 1, 211-246.
96. Webster, R. G., & Laver W. G. (1972). The origin of pandemic influenza. Bulletin of the World Health Organization, 47, 449-452.
97. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiological Reviews, 56, 152-179.
98. Weiss, R. A., & McMichael, A. J. (2004). Social and environmental risk factors in the emergence of infectious diseases. Nature Medicine, 10(Suppl. 12), S70-S76.
99. Wood, J. M. (2001). Developing vaccines against pandemic influenza. Philosophical Transactions of the Royal Society of London. Series B, 356, 1953-1960.
100. World Health Organization. (1999). Influenza Pandemic Preparedness Plan. The Role of WHO and Guidelines for National and Regional Planning. WHO, Geneva.
101. World Health Organization. (2003). Influenza Fact Sheet 11, revised March 2003 WHO, Geneva.
102. Writing Committee of the World Health Organization Consultation on Human Influenza A/H5. (2005). Avian influenza A (H5N1) infections in humans. New England Journal of Medicine, 353, 1374-1385.
103. Zebedee, S. L., & Lamb, R. A. (1988). Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. Journal of Virology, 62, 2762-2772.